Area: Decisions, Operations & Technology Management
Carbon Disclosures: Unflattering Supply Chain Data Omitted
Companies that report emissions appear greener only in a narrow measure
Can Supply Chains — Global, Opaque, Ever-Changing — Be Made Fair?
Amid the pandemic, price gouging and stiffing of suppliers and workers surged
Can Contracts Optimize Both Health Care and Clinician Pay?
Accountable care organizations can levy penalties against specialists for poor patient outcomes
Can Algorithms Help Reduce Hospital Readmissions?
Measuring the utility of increased care and testing, inputs that aren’t always immediately available
Business Efficiency Needn’t Be the Enemy of Personal and Public Well-Being
Operations managers can take into consideration happiness, equity and sustainability
Bribery and the Motivation of Bidders on Foreign Contracts
Do bigger companies win even when they lose out on corrupt deals?
BRCA Mutation: New Model Quantifies How Surgeries Reduce Cancer Risk
Informed by personal experience, a researcher parses data to help those mulling mastectomy and gynecological surgeries
Beyond Uber: When Surge Pricing Makes Business Sense
Research seeks to predict how time-based price discrimination might spread
Applying Behavioral Economics to Supply Chain Decisions
B2B relationships aren’t the rational arena classic theories would suggest
Anticipating Overcrowding Risk in the ICU
A model vastly outperforms predictions based on prior hospital data
Amid Unfounded ‘Hurricane Skepticism,’ Trump Voters Were Less Likely to Evacuate
Only after a Rush Limbaugh broadcast did evacuation rates diverge politically
Amid Technology Boom, Where Are Productivity Gains?
19th-century French cotton mills suggest halting, uneven progress
Amazon (and Other Platforms) vs. Third-Party Sellers: Complicated Debate
Some data shows competing against the platform can help sellers, if not consumers
AI’s Somewhat Hidden Secret: Invisible Human Workers
How 934 workers around the globe regard their labor; it doesn’t have to be this way
AI from AI: a Future of Generic and Biased Online Content?
Sharing the technology’s weak work product negatively influences the quality of its output going forward
A Tool to Make FDA Drug Approval Practices Transparent
Researchers aim to help the agency, drug companies and patients better understand the complex authorization process